Lab Muffin Beauty Science - Some of the moisturising products I used when I was introducing tretinoin to my retinoid-sensitive skin: ⠀ Huxley Oil Light and More and Freezeframe Rosehip Pro: I
![PDF] Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. | Semantic Scholar PDF] Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/09cd69d99c323f47f2d87a21bbff4fefb3f7a176/8-Figure7-1.png)
PDF] Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. | Semantic Scholar
![PDF) Short contact therapy with adapalen 0,3 % / benzoyl peroxide 2,5 % gel for maintenance after systemic isotretinoin treatment PDF) Short contact therapy with adapalen 0,3 % / benzoyl peroxide 2,5 % gel for maintenance after systemic isotretinoin treatment](https://i1.rgstatic.net/publication/357786993_Short_contact_therapy_with_adapalen_03_benzoyl_peroxide_25_gel_for_maintenance_after_systemic_isotretinoin_treatment/links/61ef6c1a9a753545e2f59a0f/largepreview.png)
PDF) Short contact therapy with adapalen 0,3 % / benzoyl peroxide 2,5 % gel for maintenance after systemic isotretinoin treatment
![Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor‐blinded two‐center trial: The MASCOTTE study - Bertolani - 2021 - Dermatologic Therapy - Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor‐blinded two‐center trial: The MASCOTTE study - Bertolani - 2021 - Dermatologic Therapy -](https://onlinelibrary.wiley.com/cms/asset/17e638c4-5342-4ac4-ba72-c53e40ac12de/dth14724-fig-0001-m.jpg)
Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor‐blinded two‐center trial: The MASCOTTE study - Bertolani - 2021 - Dermatologic Therapy -
![PDF] Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. | Semantic Scholar PDF] Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/09cd69d99c323f47f2d87a21bbff4fefb3f7a176/7-Figure6-1.png)
PDF] Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. | Semantic Scholar
![Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor‐blinded two‐center trial: The MASCOTTE study - Bertolani - 2021 - Dermatologic Therapy - Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor‐blinded two‐center trial: The MASCOTTE study - Bertolani - 2021 - Dermatologic Therapy -](https://onlinelibrary.wiley.com/cms/asset/6a40543e-61ef-4eac-a9ce-0703a4b28c0e/dth14724-fig-0003-m.jpg)
Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor‐blinded two‐center trial: The MASCOTTE study - Bertolani - 2021 - Dermatologic Therapy -
![Short contact therapy with adapalen 0.3%/benzoyl peroxide 2.5% gel for maintenance after systemic isotretinoin treatment - Niesert - 2022 - Dermatologic Therapy - Wiley Online Library Short contact therapy with adapalen 0.3%/benzoyl peroxide 2.5% gel for maintenance after systemic isotretinoin treatment - Niesert - 2022 - Dermatologic Therapy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0b5cbb82-3dff-47c3-a303-2cc062325129/dth15318-fig-0001-m.jpg)